Penpulimab, identified by the specific CAS number 2350298-92-7, represents a emerging therapeutic antibody currently undergoing assessment for its potential in malignancy treatment. This biological compound is designed https://mediajx.com/story28109280/penpulimab-a-deep-examination-into-the-2350298-92-7-immunoglobulin